Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Schering-Plough launches alkylating agent in second major market

June 18, 1999

GnRH antagonist A-222509: coadministration with ritonavir improves potency and PK

June 18, 1999

Cytogen acquires Prostagen, forms joint venture with Progenics

June 18, 1999

Selective, efficacious chemosensitizer discovered

June 18, 1999

Phenolic hormone inhibits smooth muscle cells in prostate tissue

June 18, 1999

Uncarinic acids with anticancer potential

June 18, 1999

New tyrosine kinase inhibitor series presented by Pfizer

June 17, 1999

Novopharm Biotech's fully human antibody vaccine enters clinical trials

June 17, 1999

MORE trial results: raloxifene prevents breast cancer in postmenopausal women

June 16, 1999

B7-2/GM-CSF immunogene therapy: a novel approach to the treatment of glioma

June 16, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
Unmasking the X: EPAC2 shifts the fragile X landscape
BioWorld
Researchers at UCLA have shown that divergent neuronal signaling in fragile X mice converges on EPAC2, a druggable target whose inhibition restores circuit...
Recludix presents STAT1/3 inhibitors for dermatological diseases
BioWorld Science
Recludix Pharma Inc. recently presented data on their new STAT1/3 inhibitors REX-6553 and REX-6547 for treating dermatological inflammatory skin diseases.